Oslo – Norway’s monarch, King Harald V, 89, was admitted to the National Hospital on Monday afternoon for treatment of a blood disease known as hemolytic anemia. The royal palace confirmed the hospitalization in a statement, noting that the king has been receiving cortisone therapy for the condition in recent weeks.
Medical background and current treatment
According to the palace, cortisone treatment has led to fluid accumulation throughout the king’s body, a complication that required inpatient care. The statement added that the king has been on sick leave for the past two weeks, during which his son, Crown Prince Haakon, has assumed regent duties.
Recent health history
King Harald’s health issues are not new. In February of this year, he was hospitalized while on vacation in Spain’s Canary Islands for a skin infection. Two years ago, the king fell ill during a private vacation with Queen Sonja in Malaysia and was fitted with a temporary pacemaker before returning to Norway on a medical flight, where a permanent pacemaker was installed.
Royal duties and succession
Harald has reigned as Norway’s king since 1991, overseeing a constitutional monarchy that emphasizes the nation’s democratic traditions and cultural heritage. While he recovers, Crown Prince Haakon will continue to perform the constitutional duties of the monarch, ensuring continuity of governance.
Public response
Norwegian citizens have expressed concern and well‑wishes for the king’s health on social media and through official channels. The royal family’s public communications have emphasized the importance of privacy and respect for the king’s recovery process.
Context of the monarchy in Norway
Norway’s monarchy, while largely ceremonial, plays a symbolic role in national unity and cultural identity. The king’s health updates are closely followed by the public, reflecting the affection many Norwegians hold for the royal family.
Medical experts note that hemolytic anemia, a condition in which red blood cells are destroyed faster than they can be produced, can lead to fatigue, jaundice, and fluid retention. Treatment typically involves managing the underlying cause and controlling symptoms, often with corticosteroids such as cortisone.
The palace has not disclosed a projected discharge date, but indicated that the king will remain under observation until the fluid accumulation is resolved and his condition stabilizes.
Original reporting: Alexandria, VA News – WTOP News — read the source article.
